Institute of Pharmacology and Neurosciences, Faculty of Medicine, University of Lisbon, Lisbon, Portugal.
Br J Pharmacol. 2009 Sep;158(1):15-22. doi: 10.1111/j.1476-5381.2009.00157.x. Epub 2009 Jun 5.
G protein coupled receptors and tropomyosin-related kinase (Trk) receptors have distinct structure and transducing mechanisms; therefore, cross-talk among them was unexpected. Evidence has, however, accumulated showing that tonic adenosine A2A receptor activity is a required step to allow synaptic actions of neurotrophic factors, namely upon synaptic transmission at both pre- and post-synaptic level as well as upon synaptic plasticity. An enhancement of A2A receptor tonus upon ageing may partially compensate the loss of TrkB receptors, rescuing to certain degree the facilitatory action of brain derived neurotrophic factor in aged animals, which might prove particularly relevant in the prevention of neurodegeneration upon ageing. A2A receptors also trigger synaptic actions of other neurotrophic factors, such as glial derived neurotrophic factor at dopaminergic striatal nerve endings. The growing evidence that tonic adenosine A2A receptor activity is a crucial step to allow actions of neurotrophic factors in neurones will be reviewed and discussed in the light of therapeutic strategies for neurodegenerative diseases.
G 蛋白偶联受体和原肌球蛋白相关激酶 (Trk) 受体具有不同的结构和转导机制;因此,它们之间的串扰是出乎意料的。然而,有证据表明,持续的腺苷 A2A 受体活性是允许神经营养因子发挥突触作用所必需的步骤,即在突触前和突触后水平的突触传递以及突触可塑性方面。随着年龄的增长,A2A 受体张力的增强可能部分补偿 TrkB 受体的丧失,在一定程度上挽救脑源性神经营养因子在老年动物中的促进作用,这在预防衰老引起的神经退行性变方面可能尤为重要。A2A 受体还触发其他神经营养因子(如多巴胺纹状体神经末梢的胶质衍生神经营养因子)的突触作用。持续的腺苷 A2A 受体活性是允许神经营养因子在神经元中发挥作用的关键步骤的证据正在增加,本文将根据神经退行性疾病的治疗策略对其进行综述和讨论。